Human IL-12 / IL-23 Monoclonal Antibody
Product Sizes
1 mg
£355.00
YR0104-1MG
5 mg
£885.00
YR0104-5MG
20 mg
£2835.00
YR0104-20MG
About this Product
- SKU:
- YR0104
- Additional Names:
- CLMF|CLMF2|IL-12B/P19|IL-23|IL-23A|IL23P19|IMD28|IMD29|NKSF|NKSF2|SGRF
- Application:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Clonality:
- Monoclonal
- Extra Details:
- What is Ustekinumab Biosimilar research grade? Ustekinumab is a human anti-IL-12 / IL-23 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Ustekinumab represents a novel approach to treating psoriasis, Multiple Sclerosis, Crohn's Disease and other autoimmune and inflammatory disorders. Ustekinumab biosimilar uses the same protein sequences as the therapeutic antibody ustekinumab.
- Formulation:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human IL-12 / IL-23
- Isotype:
- IgG1, kappa
- Molecular Weight:
- 150 kDa
- Purity:
- >95%
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ABclonal Technology
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:YR0104
